Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by dusoft24x7on Nov 01, 2015 10:03pm
121 Views
Post# 24249133

Wall Street Journal - Left now he has nothing to say - huh?

Wall Street Journal - Left now he has nothing to say - huh?
This was the hero shorties were banking on and posting all weekend. Left has left the field says he has nothing more to add or allege against Valeant... this after he tweeted dirtier than before on Friday.

That apart... Bank of America has update that VRX is BUY (1-Nov), UBS securities put over $250+

Here is what Valeant reported wilth 100% confidence today :
In a statement Sunday, Valeant called Mr. Left’s claims “sensational” and “false and misleading,” and said it was “confident in our compliance with applicable accounting rules, regulations and laws.” The company reiterated its previous comments that Mr. Left’s statements were an attempt to drive down Valeant’s stock price, and that it has asked the Securities and Exchange Commission to investigate Mr. Left and Citron.



<< Previous
Bullboard Posts
Next >>